Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement.
Quartuccio N, Panareo S, Urso L, Sturiale L, Siracusa M, Arnone A, Alongi P, Baldari S, Bartolomei M, Arnone G. Quartuccio N, et al. Among authors: siracusa m. Nucl Med Commun. 2021 Feb 1;42(2):198-204. doi: 10.1097/MNM.0000000000001321. Nucl Med Commun. 2021. PMID: 33252511
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study.
Cistaro A, Quartuccio N, Garganese MC, Villani MF, Altini C, Pizzoferro M, Piccardo A, Cabria M, Massollo M, Maghnie M, Campennì A, Siracusa M, Baldari S, Panareo S, Urso L, Bartolomei M, De Palma D, Grossi A, Mazzoletti A, Dondi F, Bertagna F, Giubbini R, Albano D. Cistaro A, et al. Among authors: siracusa m. Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1374-1385. doi: 10.1007/s00259-021-05586-8. Epub 2021 Oct 19. Eur J Nucl Med Mol Imaging. 2022. PMID: 34664092 Free PMC article.
Combined BRAFV600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation.
Campennì A, Ruggeri RM, Siracusa M, Pignata SA, Di Mauro F, Vento A, Trimarchi F, Baldari S. Campennì A, et al. Among authors: siracusa m. J Endocrinol Invest. 2018 Nov;41(11):1283-1288. doi: 10.1007/s40618-018-0864-6. Epub 2018 Mar 16. J Endocrinol Invest. 2018. PMID: 29549631
BRAF (V600E) mutation in isthmic malignant thyroid nodules.
Campennì A, Giovanella L, Alibrandi A, Siracusa M, Ruggeri RM, Baldari S. Campennì A, et al. Among authors: siracusa m. Clin Endocrinol (Oxf). 2016 Jan;84(1):152-3. doi: 10.1111/cen.12858. Epub 2015 Aug 10. Clin Endocrinol (Oxf). 2016. PMID: 26190162 No abstract available.
HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin.
Ruggeri RM, Campennì A, Giuffrè G, Giovanella L, Siracusa M, Simone A, Branca G, Scarfì R, Trimarchi F, Ieni A, Tuccari G. Ruggeri RM, et al. Among authors: siracusa m. Int J Mol Sci. 2016 Dec 6;17(12):2040. doi: 10.3390/ijms17122040. Int J Mol Sci. 2016. PMID: 27929428 Free PMC article.
144 results